Changwei Zhou

Ciltacabtagene Autoleucel, an Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up

Thomas G. Martin, Saad Z. Usmani, Jesús G. Berdeja et al. · Journal of Clinical Oncology · 2022 · 633 citations · Full text

Medicine, Hematology, Immunology +17

The promotion of neural progenitor cells proliferation by aligned and randomly oriented collagen nanofibers through β1 integrin/MAPK signaling pathway

Yansong Wang, Yao Meng, Jihui Zhou et al. · Biomaterials · 2011 · 90 citations

Life Sciences, Biomedical Engineering, Cell Biology +16

Updated Results from CARTITUDE-1: Phase 1b/2Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Patients With Relapsed/Refractory Multiple Myeloma

Thomas G. Martin, Saad Z. Usmani, Jesús G. Berdeja et al. · Blood · 2021 · 66 citations

Medicine, Hematology, Immunology +16

Tenuivirus utilizes its glycoprotein as a helper component to overcome insect midgut barriers for its circulative and propagative transmission

Gang Lü, Shuo Li, Changwei Zhou et al. · PLoS Pathogens · 2019 · 56 citations · Full text

Life Sciences, Entomology, Infectious Diseases +17

Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis

Christine V. Fontanilla, Huiying Gu, Qingpeng Liu et al. · Scientific Reports · 2015 · 43 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17